M.T. Ferrer

710 total citations
23 papers, 262 citations indexed

About

M.T. Ferrer is a scholar working on Epidemiology, Hepatology and Surgery. According to data from OpenAlex, M.T. Ferrer has authored 23 papers receiving a total of 262 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Epidemiology, 11 papers in Hepatology and 6 papers in Surgery. Recurrent topics in M.T. Ferrer's work include Liver Disease Diagnosis and Treatment (6 papers), Liver Disease and Transplantation (5 papers) and Hepatitis Viruses Studies and Epidemiology (5 papers). M.T. Ferrer is often cited by papers focused on Liver Disease Diagnosis and Treatment (6 papers), Liver Disease and Transplantation (5 papers) and Hepatitis Viruses Studies and Epidemiology (5 papers). M.T. Ferrer collaborates with scholars based in Spain, United States and Germany. M.T. Ferrer's co-authors include William R. Kennedy, Miguel Ángel Gómez‐Bravo, J.M. Pascasio, J.M. Sousa, Álvaro Giráldez Gallego, Antonio Grilo, Francisco Órtega Ruiz, Alfonso Vargas, Manoela Mota and Israel Grilo Bensusán and has published in prestigious journals such as PLoS ONE, Neurology and Gut.

In The Last Decade

M.T. Ferrer

21 papers receiving 257 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
M.T. Ferrer Spain 9 128 102 100 51 48 23 262
Henning Lorenzen Germany 7 159 1.2× 178 1.7× 161 1.6× 60 1.2× 18 0.4× 10 312
Tim Reese Germany 10 118 0.9× 61 0.6× 143 1.4× 18 0.4× 33 0.7× 35 251
M. Polacco Italy 12 209 1.6× 88 0.9× 238 2.4× 9 0.2× 50 1.0× 33 318
Berkant Sönmez Türkiye 7 35 0.3× 65 0.6× 87 0.9× 28 0.5× 36 0.8× 10 237
A Lienhart France 5 215 1.7× 69 0.7× 249 2.5× 15 0.3× 37 0.8× 14 338
Abhijit Ghatak United States 9 18 0.1× 76 0.7× 167 1.7× 25 0.5× 156 3.3× 22 307
Masanori Nakano Japan 12 64 0.5× 95 0.9× 66 0.7× 30 0.6× 8 0.2× 31 320
Kim C. Wagner Germany 9 56 0.4× 16 0.2× 85 0.8× 27 0.5× 14 0.3× 24 194
Andrew N. de la Torre United States 8 225 1.8× 108 1.1× 228 2.3× 27 0.5× 5 0.1× 15 374
Wencheng Tan China 5 79 0.6× 55 0.5× 98 1.0× 5 0.1× 54 1.1× 11 204

Countries citing papers authored by M.T. Ferrer

Since Specialization
Citations

This map shows the geographic impact of M.T. Ferrer's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by M.T. Ferrer with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites M.T. Ferrer more than expected).

Fields of papers citing papers by M.T. Ferrer

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by M.T. Ferrer. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by M.T. Ferrer. The network helps show where M.T. Ferrer may publish in the future.

Co-authorship network of co-authors of M.T. Ferrer

This figure shows the co-authorship network connecting the top 25 collaborators of M.T. Ferrer. A scholar is included among the top collaborators of M.T. Ferrer based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with M.T. Ferrer. M.T. Ferrer is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Salvador, M, et al.. (2025). Questioning latency period in causality assessment: On the hepatotoxicity of atorvastatin. Revista Española de Enfermedades Digestivas.
2.
Ferrer, M.T., María T. Grande, Gonzalo Ruiz‐Pérez, et al.. (2024). Fatty acid amide hydrolase gene inactivation induces hetero‐cellular potentiation of microglial function in the 5xFAD mouse model of Alzheimer's disease. Glia. 73(2). 352–367. 1 indexed citations
3.
Gallego, Álvaro Giráldez, Elisa Rodríguez‐Seguel, R Valencia, et al.. (2023). Three double-dose reinforced hepatitis B revaccination scheme for patients with cirrhosis unresponsive to the standard regimen: an open-label randomised clinical trial. Gut. 73(1). 166–174. 3 indexed citations
4.
5.
Cruz‐Ojeda, Patricia de la, Tobias Schmid, Loreto Boix, et al.. (2022). miR-200c-3p, miR-222-5p, and miR-512-3p Constitute a Biomarker Signature of Sorafenib Effectiveness in Advanced Hepatocellular Carcinoma. Cells. 11(17). 2673–2673. 22 indexed citations
6.
Rojas, Ángela, et al.. (2018). Performance of different biomarkers for the management of hepatocellular carcinoma. Hepatoma Research. 4(7). 31–31. 7 indexed citations
7.
González, Raúl, Alessandro Rufini, María Hernández, et al.. (2017). Role of p63 and p73 isoforms on the cell death in patients with hepatocellular carcinoma submitted to orthotopic liver transplantation. PLoS ONE. 12(3). e0174326–e0174326. 8 indexed citations
8.
Ferrer, M.T., et al.. (2017). La noradrenalina como tratamiento médico alternativo a la terlipresina en el manejo del síndrome hepatorrenal tipo 1. Gastroenterología y Hepatología. 41(7). 440–441. 1 indexed citations
9.
Bensusán, Israel Grilo, J.M. Pascasio, Francisco Órtega Ruiz, et al.. (2017). The utility of the macro-aggregated albumin lung perfusion scan in the diagnosis and prognosis of hepatopulmonary syndrome in cirrhotic patients candidates for liver transplantation. Revista Española de Enfermedades Digestivas. 109(5). 335–343. 8 indexed citations
10.
Bensusán, Israel Grilo, J.M. Pascasio, Francisco Órtega Ruiz, et al.. (2017). Hepatopulmonary syndrome: which blood gas analysis criteria and position should we use for diagnosis?. Revista Española de Enfermedades Digestivas. 109(12). 843–849. 8 indexed citations
11.
Pascasio, J.M., Israel Grilo Bensusán, Francisco Órtega Ruiz, et al.. (2014). Prevalence and Severity of Hepatopulmonary Syndrome and Its Influence on Survival in Cirrhotic Patients Evaluated for Liver Transplantation. American Journal of Transplantation. 14(6). 1391–1399. 54 indexed citations
12.
Vargas, Alfonso, M.T. Ferrer, Jesús Martı́n, et al.. (2012). Response to Vaccination Against Hepatitis B Virus with a Schedule of Four 40-μg Doses in Cirrhotic Patients Evaluated for Liver Transplantation: Factors Associated with a Response. Transplantation Proceedings. 44(6). 1499–1501. 25 indexed citations
13.
Vargas, Alfonso, M.T. Ferrer, Jesús Martín, et al.. (2012). Prevalence of Hepatitis B and A Virus Markers and Vaccination Indication in Cirrhotic Patients Evaluated for Liver Transplantation in Spain. Transplantation Proceedings. 44(6). 1502–1504. 8 indexed citations
14.
Vargas, Alfonso, Rosario García Jiménez, Jesús Martín, et al.. (2012). Prevalence and Characteristics of Bone Disease in Cirrhotic Patients Under Evaluation for Liver Transplantation. Transplantation Proceedings. 44(6). 1496–1498. 26 indexed citations
15.
Pascasio, J.M., et al.. (2008). Prevalence of Hepatitis A and B Markers and Vaccine Indication in Cirrhotic Patients Evaluated for Liver Transplantation in Spain. Transplantation Proceedings. 40(9). 2946–2948. 2 indexed citations
16.
Pascasio, J.M., et al.. (2008). 311 TERLIPRESSIN AND ALBUMIN IN CIRRHOTIC PATIENTS WITH HEPATORENAL SYNDROME TYPE-1 WITH AND WITHOUT ACTIVE INFECTION. Journal of Hepatology. 48. S123–S124. 1 indexed citations
17.
Pascasio, J.M., Arnold K. Gash, J.M. Sousa, et al.. (2008). Response to a Vaccination Schedule With 4 Doses of 40 μg Against Hepatitis B Virus in Cirrhotic Patients Evaluated for Liver Transplantation. Transplantation Proceedings. 40(9). 2943–2945. 14 indexed citations
18.
Ferrer, M.T., et al.. (2006). Desnutrición severa y efectos en el macizo craneofacial. 3(1).
19.
Ferrer, M.T., et al.. (1991). Baroreflexes in patients with diabetes mellitus. Neurology. 41(9). 1462–1462. 35 indexed citations
20.
Navarro, Xavier, William R. Kennedy, & M.T. Ferrer. (1991). Cardiovascular responses to tilting in healthy and diabetic subjects. Journal of the Neurological Sciences. 104(1). 39–45. 11 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Henning Lorenzen Breakdown of academic impact, for papers by Tim Reese Breakdown of academic impact, for papers by M. Polacco Breakdown of academic impact, for papers by Berkant Sönmez Breakdown of academic impact, for papers by A Lienhart Breakdown of academic impact, for papers by Abhijit Ghatak Breakdown of academic impact, for papers by Masanori Nakano Breakdown of academic impact, for papers by Kim C. Wagner Breakdown of academic impact, for papers by Andrew N. de la Torre Breakdown of academic impact, for papers by Wencheng Tan
Rankless by CCL
2026